Literature DB >> 10021685

Pancreatic cancer.

C J Yeo1, J L Cameron.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10021685

Source DB:  PubMed          Journal:  Curr Probl Surg        ISSN: 0011-3840            Impact factor:   1.909


× No keyword cloud information.
  18 in total

Review 1.  Diagnostic laparoscopy: indications and benefits.

Authors:  Beate Rau; Michael Hünerbein
Journal:  Langenbecks Arch Surg       Date:  2004-05-20       Impact factor: 3.445

2.  Fluorine-18-Labeled Thymidine Positron Emission Tomography (FLT-PET) as an Index of Cell Proliferation after Pharmacological Ascorbate-Based Therapy.

Authors:  John A Cieslak; Zita A Sibenaller; Susan A Walsh; Laura L Boles Ponto; Juan Du; John J Sunderland; Joseph J Cullen
Journal:  Radiat Res       Date:  2015-12-31       Impact factor: 2.841

3.  Pancreaticoduodenectomy with vascular resection for local advanced pancreatic head cancer: a single center retrospective study.

Authors:  Chunyou Wang; Heshui Wu; Jiongxin Xiong; Feng Zhou; Jing Tao; Tao Liu; Gang Zhao; Shanmiao Gou
Journal:  J Gastrointest Surg       Date:  2008-08-06       Impact factor: 3.452

4.  Surgical selection for late pancreatic head carcinoma without gastric outlet obstruction.

Authors:  Shu-Hua Zhang; Juan Wang; Chong Yang; Bo Wang; He-Shui Wu; Chun-You Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

5.  Selective inhibition of endothelin receptor A as an anti-angiogenic and anti-proliferative strategy for human pancreatic cancer.

Authors:  Sarah Bhargava; Till Stummeyer; Birgit Hotz; O Joe Hines; Howard A Reber; Heinz J Buhr; Hubert G Hotz
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

6.  Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer.

Authors:  Hubert G Hotz; Parkash S Gill; Rizwan Masood; Birgit Hotz; Heinz J Buhr; Thomas Foitzik; O Joe Hines; Howard A Reber
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

7.  Comment on "Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance.

Authors:  Joseph J Cullen; Douglas R Spitz; Garry R Buettner
Journal:  Free Radic Biol Med       Date:  2011-04-01       Impact factor: 7.376

8.  Clinical and pathologic prognostic factors for curative resection for pancreatic cancer.

Authors:  M V Perini; A L Montagnini; J Jukemura; S Penteado; E E Abdo; R Patzina; I Cecconello; J E M Cunha
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Clinical significance of p16 protein expression loss and aberrant p53 protein expression in pancreatic cancer.

Authors:  Joon Jeong; Young Nyun Park; Joon Seong Park; Dong-Sup Yoon; Hoon Sang Chi; Byong Ro Kim
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

10.  Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer.

Authors:  Juan Du; Sean M Martin; Mark Levine; Brett A Wagner; Garry R Buettner; Sih-han Wang; Agshin F Taghiyev; Changbin Du; Charles M Knudson; Joseph J Cullen
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.